Shattuck Labs price to sales ratio STTK

Market value divided by revenue over the last twelve months, since 2022.

Today, Oct 23, 2026: n/m; a sliver of sales
Last meaningful: 199×; Dec 2025
5-year median: 14.3×
5-year range: 2.9× to 199×
Peer median: 1.5×

Shattuck Labs' price to sales ratio is not a meaningful number today: a multiple this high rests on a sliver of sales.

It was last meaningful in Dec 2025, at 199×.

On the days it had one over the last 5 years, its median was 14.3×, from 2.9× in Nov 2022 to 199× in Dec 2025.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2025	199×	6.1×	199×
2024	9.2×	7.4×	189×
2023	75.5×	4.0×	197×
2022	3.2×	2.9×	188×

Against its peers

Companies in Drug Manufacturers - General nearest Shattuck Labs' size, closest first, today.

Company	Price to sales ratio
STTKShattuck Labs	n/m
PBYIPuma Biotechnology	2.5×
IRWDIronwood Pharmaceuticals	1.5×
ZVRAZevra Therapeutics	4.3×
CRMDCorMedix	1.3×
ARVNArvinas	1.5×
COLLCollegium Pharmaceutical	0.9×
ABUSArbutus Biopharma	4.6×
AMPHAmphastar Pharmaceuticals	1.5×
OMEROmeros	n/m
NATRNatures Sunshine Products	0.4×
Peer median	1.5×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Shattuck Labs

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.